Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM)

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-139332

Published: 2020

Journal Articles

Variations in Multiple Myeloma Disease Presentation By Race

Mark A Fiala, BS, CCRP, Tanya M Wildes, MD MSCI, Michael Slade, BA, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD MBA

Blood (2015) 126 (23): 5618.

https://doi.org/10.1182/blood.V126.23.5618.5618

Published: 2015

Journal Articles

CD34 + -Selected Infusions of Fresh or Cryopreserved Peripheral Blood Stem Cells for the Treatment of Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplant

Armin Ghobadi, MD, Mark A Fiala, BS, CCRP, Giridharan Ramsingh, MD, Feng Gao, PhD, Camille N. Abboud, MD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, John F. DiPersio, MD PhD

Blood (2015) 126 (23): 3098.

https://doi.org/10.1182/blood.V126.23.3098.3098

Published: 2015

Journal Articles

The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma

Mark A Fiala, BS, CCRP, Michael Slade, BA, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD MSCI, Ravi Vij, MD MBA

Blood (2015) 126 (23): 2115.

https://doi.org/10.1182/blood.V126.23.2115.2115

Published: 2015

Journal Articles

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Brian T Hess, MD, Feng Gao, PhD, John F. DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Mark A. Schroeder, MD, Iskra Pusic, MD, Armin Ghobadi, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Meagan A. Jacoby, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 1950.

https://doi.org/10.1182/blood.V126.23.1950.1950

Published: 2015

Journal Articles

Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study

Jesse Keller, MD, Mark A Fiala, BS, CCRP, Michael Slade, BA, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD MSCI, Ravi Vij, MD MBA

Blood (2015) 126 (23): 3307.

https://doi.org/10.1182/blood.V126.23.3307.3307

Published: 2015

Journal Articles

A Randomized Trial of Tbo-Filgrastim Versus Filgrastim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma

Mark A Fiala, BS, CCRP, David Schwab, BA CCRP, Ravi Vij, MD MBA, Amanda F. Cashen, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD

Blood (2015) 126 (23): 516.

https://doi.org/10.1182/blood.V126.23.516.516

Published: 2015

Journal Articles

Falls in Older Adults with Multiple Myeloma

Tanya M Wildes, MD MSCI, Mark A Fiala, BS, CCRP, Ashley E Rosko, MD, Sascha Tuchman, MD, Emily Guerard, MD, Elizabeth K. O'Donnell, MD, Erica L. Campagnaro, MD, Keith Stockerl-Goldstein, MD, Ravi Vij, MD MBA

Blood (2015) 126 (23): 4485.

https://doi.org/10.1182/blood.V126.23.4485.4485

Published: 2015

Journal Articles

The Association Between Performance Status and Health-Related Quality of Life

Mark A Fiala, BS, CCRP, Jesse Keller, MD, Michael Slade, BA, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD MBA, Tanya M Wildes, MD MSCI

Blood (2015) 126 (23): 3312.

https://doi.org/10.1182/blood.V126.23.3312.3312

Published: 2015

Journal Articles

Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Se young Han, MD, Pavan Kumar Bhamidipati, MBBS,MD, Khoan Vu, MD, John F Dipersio, MD PhD, Feng Gao, PhD, Iskra Pusic, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Camille N. Abboud, MD FACP, Keith Stockerl-Goldstein, MD, Amanda F. Cashen, MD, Todd A Fehniger, MD PhD, Rizwan Romee, MD

Blood (2015) 126 (23): 3144.

https://doi.org/10.1182/blood.V126.23.3144.3144

Published: 2015

Journal Articles

Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Amanda F. Cashen, MD, Kendall Gosch, BA, Theresa Fletcher, MS, Connie Ceriotti, RN, BSN, Armin Ghobadi, MD, Ravi Vij, MD, Keith Stockerl-Goldstein, MD, John F Dipersio, MD PhD, Camille N Abboud, MD

Blood (2015) 126 (23): 3196.

https://doi.org/10.1182/blood.V126.23.3196.3196

Published: 2015

Journal Articles

A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results

Mark A. Schroeder, MD, Jaebok Choi, PhD, Matthew L Cooper, PhD, David Schwab, BA CCRP, Sarah Willey, Jingxia (Esther) Liu, PhD, Matthew Holt, Linda Eissenberg, Iskra Pusic, MD, Armin Ghobadi, MD, Rizwan Romee, MD, John S. Welch, MD PhD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD FACP, Ravi Vij, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, John F Dipersio, MD PhD

Blood (2015) 126 (23): 1935.

https://doi.org/10.1182/blood.V126.23.1935.1935

Published: 2015

Journal Articles

Geriatric Assessment in Older Adults with Newly Diagnosed Multiple Myeloma

Tanya M Wildes, MD MSCI, Brittany Depp, Ravi Vij, MD, Keith Stockerl-Goldstein, MD, Graham Colditz, MD DrPH

Blood (2014) 124 (21): 1286.

https://doi.org/10.1182/blood.V124.21.1286.1286

Published: 2014

Journal Articles

Early Evidence of Anabolic Bone Activity of BHQ880, a Fully Human Anti-DKK1 Neutralizing Antibody: Results of a Phase 2 Study in Previously Untreated Patients with Smoldering Multiple Myeloma At Risk for Progression

Nikhil C. Munshi, MD, Rafat Abonour, MD, Joseph T. Beck, MD, William Bensinger, MD, Thierry Facon, MD, Keith Stockerl-Goldstein, MD, Rachid Baz, MD, David S Siegel, MD, PhD., Kai Neben, MD, Sagar Lonial, MD, Attaya Suvannasankha, MD, Sanela Bilic, PharmD, Sandra Chica, Subhendu Mukhopadhyay, Randi Isaacs, Sundar Jagannath, MD

Blood (2012) 120 (21): 331.

https://doi.org/10.1182/blood.V120.21.331.331

Published: 2012

Journal Articles

The Demographics and Outcomes of Patients with Multiple Myeloma Dual Refractory to or Intolerant of Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide

Tzu-Fei Wang, MD, Mark Fiala, BS, CCRP, Rohan Ahluwalia, MD, Kathryn Trinkaus, PhD, Caitlin Moliske, Doug Cox, BS, Matthew Jaenicke, BS, Keith Stockerl-Goldstein, MD, Tanya Wildes, MD, Kenneth R. Carson, MD, Michael H. Tomasson, MD, Ravi Vij, MBBS, MD

Blood (2012) 120 (21): 4050.

https://doi.org/10.1182/blood.V120.21.4050.4050

Published: 2012

Journal Articles

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

Meagan A Jacoby, MD/PhD, Michael Martin, Teresa Reineck, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Amanda Cashen, MD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Camille N. Abboud, MD

Blood (2011) 118 (21): 3633.

https://doi.org/10.1182/blood.V118.21.3633.3633

Published: 2011

Journal Articles

A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,

Giridharan Ramsingh, MD, Peter Westervelt, MD, PhD, Amanda Cashen, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD, Ryan Monahan, BA, CCRP, John F. DiPersio, MD, PhD, Ravi Vij, MD

Blood (2011) 118 (21): 3616.

https://doi.org/10.1182/blood.V118.21.3616.3616

Published: 2011

Journal Articles

Prognostic Significance of PET Imaging in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Salvage Chemotherapy and Autologous Stem Cell Transplantation.

Jacob Smeltzer, MD, Amanda F Cashen, MD, Qin Zhang, MS, Camille N. Abboud, MD, FACP, John F. DiPersio, MD, PhD, Keith Stockerl-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Peter Westervelt, MD, PhD, Nancy L Bartlett, MD, Todd A Fehniger, MD, PhD,

Blood (2009) 114 (22): 3417.

https://doi.org/10.1182/blood.V114.22.3417.3417

Published: 2009

Journal Articles

A Phase I/II Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory AML.

Geoffrey L. Uy, MD, Michael P. Rettig, PhD, Kyle McFarland, Lindsay Hladnik, PharmD, Shashikant Kulkarni, PhD, Camille N. Abboud, MD, Amanda F Cashen, MD, Keith Stockerl-Goldstein, MD, Ravi Vij, MD, Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD

Blood (2009) 114 (22): 787.

https://doi.org/10.1182/blood.V114.22.787.787

Published: 2009

Journal Articles

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

Michael G. Martin, MD, Richard Walgren, MD, PhD, Elizabeth Procknow, Peter Westervelt, MD, PhD, Camille N Abboud, MD, Amanda F Cashen, MD, Keith Stockerl-Goldstein, MD, Feng Gao, PhD, John F DiPersio, MD, PhD, Ravi Vij, MD

Blood (2008) 112 (11): 2691.

https://doi.org/10.1182/blood.V112.11.2691.2691

Published: 2008

NARROW

DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM)

Variations in Multiple Myeloma Disease Presentation By Race

CD34 + -Selected Infusions of Fresh or Cryopreserved Peripheral Blood Stem Cells for the Treatment of Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplant

The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma

Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study

A Randomized Trial of Tbo-Filgrastim Versus Filgrastim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma

Falls in Older Adults with Multiple Myeloma

The Association Between Performance Status and Health-Related Quality of Life

Addition of Mycophenolate Mofetil to Methotrexate and Tacrolimus Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

A Phase I/II Trial of Intravenous Azacitidine for Acute Gvhd Prophylaxis in Patients Undergoing Matched Unrelated Stem Cell Transplantation: Phase I Results

Geriatric Assessment in Older Adults with Newly Diagnosed Multiple Myeloma

Early Evidence of Anabolic Bone Activity of BHQ880, a Fully Human Anti-DKK1 Neutralizing Antibody: Results of a Phase 2 Study in Previously Untreated Patients with Smoldering Multiple Myeloma At Risk for Progression

The Demographics and Outcomes of Patients with Multiple Myeloma Dual Refractory to or Intolerant of Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia,

A Phase 1 Study of Concomitant High Dose Lenalidomide and 5-Azacytidine Induction in the Treatment of Acute Myeloid Leukemia,

Prognostic Significance of PET Imaging in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Salvage Chemotherapy and Autologous Stem Cell Transplantation.

A Phase I/II Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory AML.

Azacitidine-Induced Changes in the MDS Methylome Are Associated with Clinical Responses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only